News Detail
New Delhi, 8 Oct 2024: The Drugs Controller General of India (DCGI) plans to take action against drug makers that give misleading and fake information to the licensing authority.
At present, there is no provision under the Drugs Rules, 1945 to address the i......
View Details
Source : Livemint
drugmakers
DCGI
misleading info
debarment
fake documents
regulatory approvals
Drug rules
Drugs & Cosmetics Act
Related News
- Centre to amend Rules to tackle submission of forged data or documents (09-10-2024)
- More FDCs may be banned; experts found that many lack therapeutic justification (09-10-2024)
- DCGI wants qualified medical device testing officers (09-10-2024)
- Govt waives testing of cough syrups for export to key markets (09-10-2024)
- Illegal to advertise Ayurveda, Siddha drugs claiming 'miraculous' effects: Ayush ministry (08-10-2024)
- Fake and banned medicines recovered from Pradhan Mantri Jan Aushadhi Kendra, Aliganj (08-10-2024)
- 2 held in Amberpet with 84 Fake educational certificates (08-10-2024)
- Drug Menace: P&H HC directs CBI to enquire into Large-Scale Manufacturing of Tablets by Pharma Firms in HP (08-10-2024)
- Drug capsules being sold as Blue Ford, Green Parrot and John Deere will be banned (08-10-2024)
- Rajesh Narvekar takes charge as FDA Commissioner of Maharashtra (08-10-2024)